Tag: Cancer: Misc.
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes
Worse Mental Health Trajectories Seen for Survivors of Teen, Young Adult Cancer
Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy
Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals
No cases of endometrial, ovarian, vaginal, or vulvar cancer were seen
NIH Research Cuts Leave Cancer Patient Facing Hard Choice
Increases in Incidence Rates of Some Cancers Seen in Early-Onset Age Groups
Incidence rates increased in at least one early-onset age group for 14 cancers; nine also had increases in older-onset age groups
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery
Aqueous Humor Liquid Biopsy Safe in Pediatric Retinoblastoma
One mild complication occurred in 1,203 procedures, for an overall complication rate of 0.08 percent
Survivorship Interest, Knowledge Limited in Head and Neck Cancer Survivors
Most patients want to address survivorship topics in one long visit and prefer in-person visits
